Ghrelin potentiates growth hormone secretion driven by putative somatostatin withdrawal and resists inhibition by human corticotropin-releasing hormone

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 6, 2006, Pages 2441-2446

  Veldhuis, Johannes D ^a   Iranmanesh, Ali ^b   Mielke, Kristi ^a   Miles, John M ^a   Carpenter, Paul C ^a   Bowers, Cyril Y ^c  

^a MAYO CLINIC   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CORTICOTROPIN RELEASING FACTOR; GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SODIUM CHLORIDE; SOMATOSTATIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE INHIBITION; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOHISTOCHEMISTRY; NORMAL HUMAN; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION;

AGED; ARGININE; CORTICOTROPIN-RELEASING HORMONE; DOUBLE-BLIND METHOD; DRUG SYNERGISM; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MIDDLE AGED; PEPTIDE HORMONES; SOMATOSTATIN;

EID: 33744953964     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2718     Document Type: Article

References (67)

1. Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
2. Frohman LA 1996 New insights into the regulation of somatotrope function using genetic and transgenic models. Metabolism 45:1-3
3. Low MJ, Otero-Corchon V, Parlow AF, Ramirez JL, Kumar U, Patel YC, Rubinstein M 2001 Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. J Clin Invest 107:1571-1580
4. Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, Kamegai J, Sugihara H, Oikawa S, Wakabayashi I 2002 Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 109:1429-1436
5. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE 1993 GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227-232
6. Le Tissier PR, Carmignac DF, Lilley S, Sesay AK, Phelps CJ, Houston P, Mathers K, Magoulas C, Ogden D, Robinson IC 2005 Hypothalamic growth-hormone-releasing-hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene. Mol Endocrinol 19:1251-1262
7. Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frolich M, Stokvis-Brantsma WH, Wit J-M 2000 Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab 86:2459-2464
8. Baumbach WR, Carrick TA, Pausch MH, Bingham B, Carmignac D, Robinson ICAF, Houghten R, Eppler CM, Price LA, Zysk JR 1998 A linear hexapeptide somatostatin antagonist blocks somatostatin activity in vitro and influences growth hormone release in rats. Mol Pharmacol 54:864-873
9. Sugihara H, Minami S, Wakabayashi I 1989 Post-somatostatin rebound secretion of growth hormone is dependent on growth hormone-releasing factor in unrestrained female rats. J Endocrinol 122:583-591
10. Ono M, Miki N, Demura H 1991 Effect of antiserum to rat growth hormone (GH)-releasing factor on physiological GH secretion in the female rat. Endocrinology 129:1791-1796
11. Pandya N, DeMott-Friberg R, Bowers CY, Barkan AL, Jaffe CA 1998 Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J Clin Endocrinol Metab 83:1186-1189
12. Zizzari P, Halem H, Taylor J, Dong JZ, Datta R, Culler MD, Epelbaum J, Bluet-Pajot MT 2005 Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology 146:3836-3842
13. Veldhuis JD, Bowers CY 2003 Three-peptide control of pulsatile and entropic feedback-sensitive modes of growth hormone secretion: modulation by estrogen and aromatizable androgen. J Pediatr Endocrinol Metab 16:587-605
14. Farhy LS, Veldhuis JD 2005 Deterministic construct of amplifying actions of ghrelin on pulsatile GH secretion. Am J Physiol 288:R1649-R1663
15. Farhy LS, Straume M, Johnson ML, Kovatchev B, Veldhuis JD 2002 Unequal autonegative feedback by GH models the sexual dimorphism in GH secretory dynamics. Am J Physiol 282:R753-R764
16. Shah N, Evans WS, Bowers CY, Veldhuis JD 1999 Tripartite neuroendocrine activation of the human growth-hormone (GH) axis in women by continuous 24-hour GH-releasing peptide (GHRP-2) infusion: pulsatile, entropic, and nyctohemeral mechanisms. J Clin Endocrinol Metab 84:2140-2150
17. Veldhuis JD, Evans WS, Bowers CY 2002 Impact of estradiol supplementation on dual peptidyl drive of growth-hormone secretion in postmenopausal women. J Clin Endocrinol Metab 87:859-866
18. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K 2001 A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 86:4552
19. Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E 2001 Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86:1169-1174
20. Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD 2004 Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. J Clin Endocrinol Metab 89:2290-2300
21. Di Vito L, Broglio F, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Ghigo E, Arvat E 2002 The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin Endocrinol (Oxf) 56:643-648
22. Massoud AF, Hindmarsh PC, Brook CGD 1997 Interaction of the growth hormone-releasing peptide hexarelin with somatostatin. Clin Endocrinol (Oxf) 47:537-547
23. Calabresi E, Ishikawa E, Bartolini L, Delitala G, Fanciulli G, Oliva O, Veldhuis JD, Serio M 1996 Somatostatin infusion suppresses GH secretory burst number and mass in normal men: a dual mechanism of inhibition. Am J Physiol 270:E975-E979
24. Arvat E, Gianotti L, Divito L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E 1995 Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 61:51-56
25. Iranmanesh A, Bowers CY, Veldhuis JD 2004 Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men. J Clin Endocrinol Metab 89:4581-4587
26. Broglio F, Benso A, Gottero C, Prodam F, Grottoli S, Tassone F, Maccario M, Casanueva FF, Dieguez C, Deghenghi R, Ghigo E, Arvat E 2002 Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol (Oxf) 57:265-271
27. Ghigo E, Arvat E, Valente F 1991 Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology 54:291-294
28. Alba-Roth J, Muller OA, Schopohl J, Von Werder K 1988 Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 67:1186-1189
29. Arvat E, Ceda GP, Di Vito L, Ramunni J, Gianotti L, Ghigo E 1998 Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging. Pituitary 1:51-58
30. Peterfreund RA, Vale WW 1983 Ovine corticotropin-releasing factor stimulates somatostatin secretion from cultured brain cells. Endocrinology 112: 1275-1278
31. Rivier C, Vale W 1985 Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. Endocrinology 117:2478-2482
32. Mozid AM, Tringali G, Forsling ML, Hendricks MS, Ajodha S, Edwards R, Navarra P, Grossman AB, Korbonits M 2003 Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm Metab Res 35:455-459
33. Holsboer F, von Bardeleben U, Steiger A 1988 Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 48:32-38
34. Muccioli G, Papotti M, Locatelli V, Ghigo E, Deghenghi R 2001 Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J Endocrinol Invest 24:RC7-RC9
35. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR 2001 Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
36. Weikel JC, Wichniak A, Ising M, Brunner H, Friess E, Held K, Mathias S, Schmid DA, Uhr M, Steiger A 2003 Ghrelin promotes slow-wave sleep in humans. Am J Physiol 284:E407-E415
37. Veldhuis JD, Keenan DM, Roelfsema F, Iranmanesh A 2005 Aging-related adaptations in the corticotropic axis: modulation by gender. Endocrinol Metab Clin North Am 34:993-1014
38. Shah N, Evans WS, Veldhuis JD 1999 Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion. Am J Physiol 276:R1351-R1358
39. Erickson D, Keenan DM, Mielke K, Bradford K, Bowers CY, Miles JM, Veldhuis JD 2004 Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp. J Clin Endocrinol Metab 89:4746-4754
40. Akamizu T, Takaya K, Irako T, Hosoda H, Teramukai S, Matsuyama A, Tada H, Miura K, Shimizu A, Fukushima M, Yokode M, Tanaka K, Kangawa K 2004 Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol 150:447-455
41. Merimee TJ, Rabinowitz D, Fineberg SE 1969 Arginine-initiated release of human growth hormone. Factors modifying the response in normal men. N Engl J Med 281:1434-1438
42. Schurmeyer TH, Avgerinos PC, Gold PW, Gallucci WT, Tomai TP, Cutler Jr GB, Loriaux DL, Chrousos GP 1984 Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. J Clin Endocrinol Metab 59:1103-1108
43. Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML 1989 Amplitude modulation of a burst-like mode of cortisol secretion subserves the circadian glucocorticoid rhythm in man. Am J Physiol 257:E6-E14
44. Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G 1990 Amplitude, but not frequency, modulation of ACTH secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man. J Clin Endocrinol Metab 71:452-463
45. Anderson SM, Wideman L, Patrie JT, Weltman A, Bowers CY, Veldhuis JD 2001 Estradiol supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion. J Clin Endocrinol Metab 86:5904-5911
46. O'Brien PC 1983 The appropriateness of analysis of variance and multiple-comparison procedures. Biometrics 39:787-794
47. Korbonits M, Little JA, Forsling ML, Tringali G, Costa A, Navarra P, Trainer PJ, Grossman AB 1999 The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol 11:521-528
48. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, van der Ploeg LH, Howard AD 1997 Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48:23-29
49. Veldhuis JD, Roemmich JN, Richmond EJ, Bowers CY 2006 Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocr Rev 20:101-140
50. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M, Razafindraibe H, Conte-Devolx B, Deghenghi R, Lenaerts V 1994 Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 135:1073-1076
51. Wren AM, Small CJ, Fribbens CV, Neary NM, Ward HL, Seal LJ, Ghatei MA, Bloom SR 2002 The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 76:316-324
52. Fletcher TP, Thomas GB, Clarke IJ 1996 Growth hormone-releasing and somatostatin concentrations in the hypophysial portal blood of conscious sheep during the infusion of growth hormone-releasing peptide-6. Domest Anim Endocrinol 13:251-258
53. Fairhall KM, Mynett A, Robinson ICAF 1995 Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J Endocrinol 144:555-560
54. Bowers CY, Granda-Ayala R 1996 GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans. J Pediatr Endocrinol Metab 9(Suppl 3):261-270
55. Keenan DM, Veldhuis JD 2003 Mathematical modeling of receptor-mediated interlinked systems. In: Henry H, Norman A, eds. Encyclopedia of hormones. San Diego: Academic Press; 286-294
56. Bowers CY 2002 New insight into the control of growth hormone secretion. In: Kleinberg DL, Clemmons DR, eds. Central and peripheral mechanisms in pituitary disease. Bristol, UK: BioScientifica; 163-175
57. Rigamonti AE, Cavallera G, Bonomo S, Deghenghi R, Locatelli V, Cella SG, Muller EE 2001 Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide. Eur J Endocrinol 145:635-644
58. Rigamonti AE, Bonomo SM, Cella SG, Muller EE 2002 GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide. J Endocrinol 174:387-394
59. Raza J, Massoud AF, Hindmarsh PC, Robinson IC, Brook CG 1998 Direct effects of corticotrophin-releasing hormone on stimulated growth hormone secretion. Clin Endocrinol (Oxf) 48:217-222
60. Ur E, Capstick C, McLoughlin L, Checkley S, Besser GM, Grossman A 1995 Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man. Neuroendocrinology 61:191-197
61. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K 2000 Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911
62. Born J, Ditschunet I, Schreiber M, Dodt C, Fehm HL 1995 Effects of age and gender on pituitary-adrenocortical responsiveness in humans. Eur J Endocrinol 132:705-711
63. Veldhuis JD, Evans WS, Bowers CY 2003 Estradiol supplementation enhances submaximal feedforward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu. J Clin Endocrinol Metab 88:5484-5489
64. Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD 2001 Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women. J Clin Endocrinol Metab 86:551-560
65. Evans WS, Anderson SM, Hull LT, Azimi PP, Bowers CY, Veldhuis JD 2001 Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1,44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states. J Clin Endocrinol Metab 86:700-712
66. Van den Berghe G 2000 Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 143:1-13
67. Sun Y, Ahmed S, Smith RG 2003 Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23:7973-7981